investors

Invizyne IPO comments by CEO Michael Heltzen

116 views September 26, 2024

Today's Nasdaq IPO marks new era of biomanufacturing - pioneered by Invizyne's breakthrough...

investors

Dr. Lalonde: From two years and 25 scientists to a few...

21 views August 08, 2024

Dr. Lalonde: From two years and 25 scientists to a few scientists for a few months "When I...

investors

Dr. Lalonde: Invizyne [...] helps the sustainability of...

34 views August 08, 2024

"Invizyne is taking what nature has done and [...] putting things in a manufacturing format so we...

investors

NREL (DoE): What Invizyne is working on is a game changer

19 views August 02, 2024

Yannick Bomble, PhD, Group Research Manager III-Biological Science at NREL (DoE), states: "What...

investors

Interview: NREL (DoE) working with Invizyne

138 views July 29, 2024

NREL (DoE) working with Invizyne in their 'Advancing Clean Tech to Energize the Future' project -...

investors

Commercializing Invizyne’s cell-free platform - fireside...

89 views July 30, 2024

Commercializing Invizyne’s cell-free platform - fireside chat withZachary Karl, PhD, Vice...

investors

Invizyne IPO - KOL Call with Dr. James J. Lalonde (July...

106 views July 17, 2024

MDB Capital President and Chief Market Strategist Lou Basenese talks with Dr. James J. Lalonde, a...

investors

Invizyne presented by Michael Heltzen & Tyler Korman

451 views June 28, 2024

In this video, CEO of Invizyne, Michael Heltzen - and VP of Research, Tyler Korman, PhD -...

investors

Invizyne presented by Chris Marlett

160 views June 12, 2024

In this video, CEO of MDB Capital Holdings, Chris Marlett, presents Invizyne. Invizyne is a...

interview

The story of Invizyne: Interview with Tyler Korman and...

489 views May 22, 2024

In this video you'll hear Invizyne co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD...